Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06503939
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-07-14
Brief Title:
Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICSLABA
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICSLABA
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study collected 600 patients evaluated whether patients had airway hyperreactivity airway inflammation specific types and allergic reactions comprehensively analyzed and classified the causes of chronic cough in patients and evaluated and compared the improvement of cough symptoms and quality of life after ICS or ICSLABA treatment
Detailed Description:
The subjects of this study were patients with chronic cough who were admitted to the Department of Respiratory and Critical Care Medicine Xiangya Hospital Central South University from September 1 2023 to December 31 2024 Patients are registered if they meet all of the following criteria 1 18 years of age 2 A clear history of COVID-19 infection with a positive nucleic acid or antigen test before chronic cough3 Persistent cough for more than 8 weeks after the acute phase of COVID-19 infection has disappeared 4 Chest X-ray andor chest CT without significant evidence of lung disease 5 No history of chronic cough 8 weeks prior to COVID-19 infection Patients who met any of the following criteria were excluded 1 Patients refused pulmonary function blood tests 2 The patient has previously been diagnosed with respiratory diseases with cough as one of the main symptoms including cough variant asthma allergic bronchitis eosinophilic bronchitis gastroesophageal reflux disease chronic obstructive pulmonary disease chronic bronchitis bronchiectasis interstitial lung disease pulmonarytracheobronchial tuberculosis etc 3 Patients who are pregnant or breastfeeding 4 The patients medical records are incomplete 5 Patients lost to follow-up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None